Drug intelligence / Profile preview

atorvastatin + ascorbic acid

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Atorvastatin + ascorbic acid is a combination of two active ingredients: atorvastatin, a statin (HMG-CoA reductase inhibitor) used to lower cholesterol and reduce cardiovascular risk, and ascorbic acid (vitamin C), an essential nutrient with antioxidant properties. This combination has been studied for its potential synergistic effects in specific clinical settings. For example, research indicates that the combined use of oral atorvastatin and vitamin C may be more effective than atorvastatin alone in reducing the incidence of postoperative atrial fibrillation after coronary artery bypass graft surgery[2]. Additionally, cocrystal formulations of these two agents have been explored to improve dissolution rates and safety profiles in preclinical models[3]. Atorvastatin works by inhibiting HMG-CoA reductase, thereby lowering LDL cholesterol and triglycerides while increasing HDL cholesterol[5][7]. Ascorbic acid acts primarily as an antioxidant and supports various enzymatic reactions.

Other names
Atorvastatin-Ascorbic acidAtorvastatin and Ascorbic Acid for CIN Prevention
02

Targets

HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)

Beyond the preview

Go deeper on atorvastatin + ascorbic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on atorvastatin + ascorbic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call